Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, effective February 1, 2025, Nova Scotia is publicly funding Pluvictotm (lutetium (177Lu) vipivotide tetraxetan ...
Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, effective February 1, 2025, Nova Scotia is publicly funding Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan injection), ...
If the scientists could very precisely measure the proportions of lutetium and halfnium in moon rocks compared to other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback